Evaluation of the Benefits for Overall Health Following Cochlear Implant Treatment in the Elderly Population
NCT ID: NCT03072862
Last Updated: 2024-01-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2017-11-06
2022-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cochlear Implantation in the Elderly
NCT05992779
Hearing Loss in Older Adults Study
NCT03382769
Observation of Benefits for Patients Implanted With a Hearing Implant of the Company Cochlear
NCT02004353
MeasurIng and Restoring Auditory Awareness for Cochlear Implant Listeners in noisE
NCT06420921
Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults
NCT02729402
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Commercial Nucleus Cochlear Implant Systems
Commercial Nucleus Cochlear Implant Systems
Commercially available Nucleus Cochlear Implant Systems, including Data Logging functionality
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Commercial Nucleus Cochlear Implant Systems
Commercially available Nucleus Cochlear Implant Systems, including Data Logging functionality
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥ 60 years at first unilateral cochlear implant
* Implant ear: meets all local criteria for cochlear implant treatment
* Contralateral ear: average pure tone thresholds indicate a moderately-severe to profound hearing loss (4 freq. average: 0.5, 1, 2 and 3 or 4 kHz \> 56 dBHL).
* Willingness to participate in and to comply with all study procedures
* Fluency in languages used to assess clinical performance
* Appropriate expectations from routine cochlear implant treatment
* Able to decide on study participation personally and independently sign their consent
Exclusion Criteria
* Unable to provide consent personally
* Unable to complete questionnaires for self-assessment independently
* Unilateral hearing loss
* Sequential and simultaneous bilateral cochlear implant recipients
* Ossification or other cochlear anomalies preventing full electrode insertion
* Retro cochlear or central origins of hearing impairment.
* Significant comorbidities preventing study participation (e.g. blindness, immobility or in a wheel chair, severe aphasia)
* Medical contraindications to surgery
* Clinic Standard fail criteria for cochlear implant candidacy in regards to chronic depression, dementia, and cognitive disorders.
* Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cochlear
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bart Volckaerts, PhD
Role: STUDY_DIRECTOR
Cochlear
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier de La Pitié Salpétrière
Paris, , France
ENT Department-Hôpital Purpan
Toulouse, , France
Bnai Zion Medical Center
Haifa, , Israel
Rabin Medical Center (Beilinson)
Petah Tikva, , Israel
ENT Otosurgery Department-Azienda Ospedaliera di Padova
Padua, , Italy
ENT Department Ospedale Guglielmo da Saliceto
Piacenza, , Italy
Complejo Hospitalario Universitario Insular Materno Infantil
Las Palmas de Gran Canaria, , Spain
Clinica Universitaria de Navarra
Pamplona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cuda D, Manrique M, Ramos A, Marx M, Bovo R, Khnifes R, Hilly O, Belmin J, Stripeikyte G, Graham PL, James CJ, Greenham PV, Mosnier I. Improving quality of life in the elderly: hearing loss treatment with cochlear implants. BMC Geriatr. 2024 Jan 4;24(1):16. doi: 10.1186/s12877-023-04642-2.
Marx M, Mosnier I, Belmin J, Wyss J, Coudert-Koall C, Ramos A, Manrique Huarte R, Khnifes R, Hilly O, Martini A, Cuda D. Healthy aging in elderly cochlear implant recipients: a multinational observational study. BMC Geriatr. 2020 Jul 23;20(1):252. doi: 10.1186/s12877-020-01628-2.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEL5671
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.